Increased soluble interleukin 2 receptor levels in schizophrenia

被引:27
作者
Gaughran, F
O'Neill, E
Cole, M
Collins, K
Daly, RJ
机构
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland
关键词
soluble interleukin 2 receptor; schizophrenia; neurodevelopment; immunology; cytokine;
D O I
10.1016/S0920-9964(97)00099-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Immunological mechanisms have been implicated in schizophrenia, but laboratory results have been variable. We evaluated soluble interleukin 2 receptor (sIL2R alpha) levels in sera of Irish patients with schizophrenia. Twenty-seven patients, 12 females and 15 males, with schizophrenia or schizophreniform psychosis, were sampled, along with 32 controls. Diagnosis was made using the Structured Clinical Interview for DSM IIIR. All but one of the patient group were in the first fortnight of an acute hospital admission. Soluble IL2R alpha: levels were measured by ELISA. Soluble IL2R alpha levels were significantly higher (two-tailed p = 0.0019) in patients (median = 1010.4 pg/ml, range = 748.7-5673.3 pg/ml) than in controls (median = 792.3 pg/ml, range = 399.6-1479.5 pg/ml). The elevated sIL2R alpha levels in an Irish population with schizophrenia are consistent with other reports and support the implication of immunological mechanisms in this disorder. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 41 条
[11]   ALTERED INTERLEUKIN-2 PRODUCTION IN SCHIZOPHRENIA - ASSOCIATION BETWEEN CLINICAL STATE AND AUTOANTIBODY PRODUCTION [J].
GANGULI, R ;
BRAR, JS ;
SOLOMON, W ;
CHENGAPPA, KNR ;
RABIN, BS .
PSYCHIATRY RESEARCH, 1992, 44 (02) :113-123
[12]  
GANGULI R, 1995, ARCH GEN PSYCHIAT, V52, P878
[13]   ABNORMALITIES IN SERUM CONCENTRATIONS OF INTERLEUKIN-2, INTERFERON-ALPHA AND INTERFERON-GAMMA IN SCHIZOPHRENIA NOT DETECTED [J].
GATTAZ, WF ;
DALGALARRONDO, P ;
SCHRODER, HC .
SCHIZOPHRENIA RESEARCH, 1992, 6 (03) :237-241
[14]  
GLASER R, 1990, ARCH GEN PSYCHIAT, V47, P707
[15]  
HANISCH UK, 1993, J NEUROSCI, V13, P3368
[16]   CAN AUTOIMMUNE MECHANISMS ACCOUNT FOR THE GENETIC PREDISPOSITION TO SCHIZOPHRENIA [J].
KNIGHT, J ;
KNIGHT, A ;
UNGVARI, G .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :533-540
[17]   A ROLE FOR INTERLEUKIN-2 IN THE REGULATION OF STRIATAL DOPAMINERGIC FUNCTION [J].
LAPCHAK, PA .
NEUROREPORT, 1992, 3 (02) :165-168
[18]   ELEVATED CENTRAL LEVELS OF INTERLEUKIN-2 IN DRUG-FREE SCHIZOPHRENIC-PATIENTS [J].
LICINIO, J ;
KRYSTAL, JH ;
SEIBYL, JP ;
ALTEMUS, M ;
CHARNEY, DS .
SCHIZOPHRENIA RESEARCH, 1991, 4 (03) :372-372
[19]   PLASMA-SOLUBLE INTERLEUKIN-2 AND TRANSFERRIN RECEPTOR IN SCHIZOPHRENIA AND MAJOR DEPRESSION [J].
MAES, M ;
MELTZER, HY ;
BUCKLEY, P ;
BOSMANS, E .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1995, 244 (06) :325-329
[20]   IMMUNE-INFLAMMATORY MARKERS IN SCHIZOPHRENIA - COMPARISON TO NORMAL CONTROLS AND EFFECTS OF CLOZAPINE [J].
MAES, M ;
MELTZER, HY ;
BOSMANS, E .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 (05) :346-351